Emergent BioSolutions Announces Closing of $100 Million Asset-Backed Loan Facility — Oct 2nd, 2024

Emergent BioSolutions GAITHERSBURG, Md., Oct. 02, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) announced today that it entered into a new credit agreement on September 30, 2024 providing for an asset-based revolving loan facility (ABL) with the lenders party thereto and...

High Growth Tech Stocks To Watch This October 2024 — Oct 1st, 2024

Over the last 7 days, the market has remained flat, but over the past 12 months, it has risen by an impressive 33%, with earnings forecast to grow by 15% annually. In such a dynamic environment, identifying high growth tech stocks that can capitalize on these trends becomes crucial for inv...

Emergent BioSolutions Inc. (EBS): A Standout Among Best Performing Cheap Stocks in 2024 — Oct 11th, 2024

We recently published a list of 12 Best Performing Cheap Stocks in 2024. In this article, we are going to take a look at where Emergent BioSolutions Inc. (NYSE:EBS) stands against other best performing cheap stocks in 2024. As we step into the final quarter of 2024, the financial markets ...

Emergent BioSolutions Confirms Approximately $400 million in Orders in 2024 & 2025 to Support Smallpox and Mpox Preparedness Efforts — Sep 25th, 2024

Emergent BioSolutions $185+ million in incremental orders for ACAM2000® and VIGIV to be delivered in 2024 and 2025 GAITHERSBURG, Md., Sept. 25, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced it has secured approximately $400 million in orders in 2024 an...

Emergent BioSolutions Demonstrates Commitment to Increasing Access & Awareness of NARCAN® Nasal Spray to Help Combat the Opioid Epidemic — Oct 8th, 2024

Emergent BioSolutions Ongoing support of the ‘White House Challenge to Save Lives from Overdose’ through workplace and public safety measures One-year mark of Ready to Rescue public awareness campaign to expand awareness, particularly among young adults and vulnerable communities 20,0...

Emergent BioSolutions Confirms Approximately $400 million in Orders in 2024 & 2025 to Support Smallpox and Mpox Preparedness Efforts — Sep 25th, 2024

Emergent BioSolutions $185+ million in incremental orders for ACAM2000® and VIGIV to be delivered in 2024 and 2025 GAITHERSBURG, Md., Sept. 25, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced it has secured approximately $400 million in orders in 2024 an...

Emergent BioSolutions Demonstrates Commitment to Increasing Access & Awareness of NARCAN® Nasal Spray to Help Combat the Opioid Epidemic — Oct 8th, 2024

Emergent BioSolutions Ongoing support of the ‘White House Challenge to Save Lives from Overdose’ through workplace and public safety measures One-year mark of Ready to Rescue public awareness campaign to expand awareness, particularly among young adults and vulnerable communities 20,0...

High Growth Tech Stocks To Watch This October 2024 — Oct 1st, 2024

Over the last 7 days, the market has remained flat, but over the past 12 months, it has risen by an impressive 33%, with earnings forecast to grow by 15% annually. In such a dynamic environment, identifying high growth tech stocks that can capitalize on these trends becomes crucial for inv...

High Growth Tech Stocks To Watch This October 2024 — Oct 1st, 2024

Over the last 7 days, the market has remained flat, but over the past 12 months, it has risen by an impressive 33%, with earnings forecast to grow by 15% annually. In such a dynamic environment, identifying high growth tech stocks that can capitalize on these trends becomes crucial for inv...

Emergent BioSolutions Announces the Execution of Contract Options Valued at $67.4 Million to Procure Additional TEMBEXA® (brincidofovir) to Support National Preparedness Efforts — Sep 26th, 2024

Emergent BioSolutions GAITHERSBURG, Md., Sept. 26, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) (“Emergent”) today announced that two contract options have been secured to procure additional treatment courses of TEMBEXA® (brincidofovir) to sustain the U.S. governm...

Emergent BioSolutions Demonstrates Commitment to Increasing Access & Awareness of NARCAN® Nasal Spray to Help Combat the Opioid Epidemic — Oct 8th, 2024

Emergent BioSolutions Ongoing support of the ‘White House Challenge to Save Lives from Overdose’ through workplace and public safety measures One-year mark of Ready to Rescue public awareness campaign to expand awareness, particularly among young adults and vulnerable communities 20,0...

Emergent BioSolutions Announces Closing of $100 Million Asset-Backed Loan Facility — Oct 2nd, 2024

Emergent BioSolutions GAITHERSBURG, Md., Oct. 02, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) announced today that it entered into a new credit agreement on September 30, 2024 providing for an asset-based revolving loan facility (ABL) with the lenders party thereto and...

Emergent BioSolutions Announces Closing of $100 Million Asset-Backed Loan Facility — Oct 2nd, 2024

Emergent BioSolutions GAITHERSBURG, Md., Oct. 02, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) announced today that it entered into a new credit agreement on September 30, 2024 providing for an asset-based revolving loan facility (ABL) with the lenders party thereto and...

High Growth Tech Stocks To Watch This October 2024 — Oct 1st, 2024

Over the last 7 days, the market has remained flat, but over the past 12 months, it has risen by an impressive 33%, with earnings forecast to grow by 15% annually. In such a dynamic environment, identifying high growth tech stocks that can capitalize on these trends becomes crucial for inv...

Emergent BioSolutions Announces Closing of $100 Million Asset-Backed Loan Facility — Oct 2nd, 2024

Emergent BioSolutions GAITHERSBURG, Md., Oct. 02, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) announced today that it entered into a new credit agreement on September 30, 2024 providing for an asset-based revolving loan facility (ABL) with the lenders party thereto and...

Emergent BioSolutions Announces Closing of $100 Million Asset-Backed Loan Facility — Oct 2nd, 2024

Emergent BioSolutions GAITHERSBURG, Md., Oct. 02, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) announced today that it entered into a new credit agreement on September 30, 2024 providing for an asset-based revolving loan facility (ABL) with the lenders party thereto and...

Emergent BioSolutions Demonstrates Commitment to Increasing Access & Awareness of NARCAN® Nasal Spray to Help Combat the Opioid Epidemic — Oct 8th, 2024

Emergent BioSolutions Ongoing support of the ‘White House Challenge to Save Lives from Overdose’ through workplace and public safety measures One-year mark of Ready to Rescue public awareness campaign to expand awareness, particularly among young adults and vulnerable communities 20,0...

Emergent BioSolutions Inc. (EBS): A Standout Among Best Performing Cheap Stocks in 2024 — Oct 11th, 2024

We recently published a list of 12 Best Performing Cheap Stocks in 2024. In this article, we are going to take a look at where Emergent BioSolutions Inc. (NYSE:EBS) stands against other best performing cheap stocks in 2024. As we step into the final quarter of 2024, the financial markets ...

Emergent BioSolutions Announces Closing of $100 Million Asset-Backed Loan Facility — Oct 2nd, 2024

Emergent BioSolutions GAITHERSBURG, Md., Oct. 02, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) announced today that it entered into a new credit agreement on September 30, 2024 providing for an asset-based revolving loan facility (ABL) with the lenders party thereto and...

Emergent BioSolutions Announces Closing of $100 Million Asset-Backed Loan Facility — Oct 2nd, 2024

Emergent BioSolutions GAITHERSBURG, Md., Oct. 02, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) announced today that it entered into a new credit agreement on September 30, 2024 providing for an asset-based revolving loan facility (ABL) with the lenders party thereto and...

Emergent BioSolutions Announces Closing of $100 Million Asset-Backed Loan Facility — Oct 2nd, 2024

Emergent BioSolutions GAITHERSBURG, Md., Oct. 02, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) announced today that it entered into a new credit agreement on September 30, 2024 providing for an asset-based revolving loan facility (ABL) with the lenders party thereto and...

Emergent BioSolutions Inc. (EBS): A Standout Among Best Performing Cheap Stocks in 2024 — Oct 11th, 2024

We recently published a list of 12 Best Performing Cheap Stocks in 2024. In this article, we are going to take a look at where Emergent BioSolutions Inc. (NYSE:EBS) stands against other best performing cheap stocks in 2024. As we step into the final quarter of 2024, the financial markets ...

Emergent BioSolutions Inc. (EBS): A Standout Among Best Performing Cheap Stocks in 2024 — Oct 11th, 2024

We recently published a list of 12 Best Performing Cheap Stocks in 2024. In this article, we are going to take a look at where Emergent BioSolutions Inc. (NYSE:EBS) stands against other best performing cheap stocks in 2024. As we step into the final quarter of 2024, the financial markets ...

Emergent BioSolutions Inc.'s (NYSE:EBS) institutional investors lost 16% last week but have benefitted from longer-term gains — Sep 24th, 2024

Key Insights Institutions' substantial holdings in Emergent BioSolutions implies that they have significant influence over the company's share price A total of 25 investors have a majority stake in the company with 41% ownership Ownership research, combined with past performance data ca...

Emergent BioSolutions Inc. (EBS): A Standout Among Best Performing Cheap Stocks in 2024 — Oct 11th, 2024

We recently published a list of 12 Best Performing Cheap Stocks in 2024. In this article, we are going to take a look at where Emergent BioSolutions Inc. (NYSE:EBS) stands against other best performing cheap stocks in 2024. As we step into the final quarter of 2024, the financial markets ...

Emergent BioSolutions Demonstrates Commitment to Increasing Access & Awareness of NARCAN® Nasal Spray to Help Combat the Opioid Epidemic — Oct 8th, 2024

Emergent BioSolutions Ongoing support of the ‘White House Challenge to Save Lives from Overdose’ through workplace and public safety measures One-year mark of Ready to Rescue public awareness campaign to expand awareness, particularly among young adults and vulnerable communities 20,0...

Emergent BioSolutions Demonstrates Commitment to Increasing Access & Awareness of NARCAN® Nasal Spray to Help Combat the Opioid Epidemic — Oct 8th, 2024

Emergent BioSolutions Ongoing support of the ‘White House Challenge to Save Lives from Overdose’ through workplace and public safety measures One-year mark of Ready to Rescue public awareness campaign to expand awareness, particularly among young adults and vulnerable communities 20,0...

High Growth Tech Stocks To Watch This October 2024 — Oct 1st, 2024

Over the last 7 days, the market has remained flat, but over the past 12 months, it has risen by an impressive 33%, with earnings forecast to grow by 15% annually. In such a dynamic environment, identifying high growth tech stocks that can capitalize on these trends becomes crucial for inv...

Emergent BioSolutions Announces the Execution of Contract Options Valued at $67.4 Million to Procure Additional TEMBEXA® (brincidofovir) to Support National Preparedness Efforts — Sep 26th, 2024

Emergent BioSolutions GAITHERSBURG, Md., Sept. 26, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) (“Emergent”) today announced that two contract options have been secured to procure additional treatment courses of TEMBEXA® (brincidofovir) to sustain the U.S. governm...

Emergent BioSolutions Demonstrates Commitment to Increasing Access & Awareness of NARCAN® Nasal Spray to Help Combat the Opioid Epidemic — Oct 8th, 2024

Emergent BioSolutions Ongoing support of the ‘White House Challenge to Save Lives from Overdose’ through workplace and public safety measures One-year mark of Ready to Rescue public awareness campaign to expand awareness, particularly among young adults and vulnerable communities 20,0...

Emergent BioSolutions Announces Closing of $100 Million Asset-Backed Loan Facility — Oct 2nd, 2024

Emergent BioSolutions GAITHERSBURG, Md., Oct. 02, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) announced today that it entered into a new credit agreement on September 30, 2024 providing for an asset-based revolving loan facility (ABL) with the lenders party thereto and...

High Growth Tech Stocks To Watch This October 2024 — Oct 1st, 2024

Over the last 7 days, the market has remained flat, but over the past 12 months, it has risen by an impressive 33%, with earnings forecast to grow by 15% annually. In such a dynamic environment, identifying high growth tech stocks that can capitalize on these trends becomes crucial for inv...

High Growth Tech Stocks To Watch This October 2024 — Oct 1st, 2024

Over the last 7 days, the market has remained flat, but over the past 12 months, it has risen by an impressive 33%, with earnings forecast to grow by 15% annually. In such a dynamic environment, identifying high growth tech stocks that can capitalize on these trends becomes crucial for inv...

Emergent BioSolutions Inc. (EBS): A Standout Among Best Performing Cheap Stocks in 2024 — Oct 11th, 2024

We recently published a list of 12 Best Performing Cheap Stocks in 2024. In this article, we are going to take a look at where Emergent BioSolutions Inc. (NYSE:EBS) stands against other best performing cheap stocks in 2024. As we step into the final quarter of 2024, the financial markets ...

Emergent BioSolutions Inc. (EBS): A Standout Among Best Performing Cheap Stocks in 2024 — Oct 11th, 2024

We recently published a list of 12 Best Performing Cheap Stocks in 2024. In this article, we are going to take a look at where Emergent BioSolutions Inc. (NYSE:EBS) stands against other best performing cheap stocks in 2024. As we step into the final quarter of 2024, the financial markets ...

High Growth Tech Stocks To Watch This October 2024 — Oct 1st, 2024

Over the last 7 days, the market has remained flat, but over the past 12 months, it has risen by an impressive 33%, with earnings forecast to grow by 15% annually. In such a dynamic environment, identifying high growth tech stocks that can capitalize on these trends becomes crucial for inv...

Emergent BioSolutions Announces the Execution of Contract Options Valued at $67.4 Million to Procure Additional TEMBEXA® (brincidofovir) to Support National Preparedness Efforts — Sep 26th, 2024

Emergent BioSolutions GAITHERSBURG, Md., Sept. 26, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) (“Emergent”) today announced that two contract options have been secured to procure additional treatment courses of TEMBEXA® (brincidofovir) to sustain the U.S. governm...

Emergent BioSolutions Inc. (EBS): A Standout Among Best Performing Cheap Stocks in 2024 — Oct 11th, 2024

We recently published a list of 12 Best Performing Cheap Stocks in 2024. In this article, we are going to take a look at where Emergent BioSolutions Inc. (NYSE:EBS) stands against other best performing cheap stocks in 2024. As we step into the final quarter of 2024, the financial markets ...

Emergent BioSolutions Demonstrates Commitment to Increasing Access & Awareness of NARCAN® Nasal Spray to Help Combat the Opioid Epidemic — Oct 8th, 2024

Emergent BioSolutions Ongoing support of the ‘White House Challenge to Save Lives from Overdose’ through workplace and public safety measures One-year mark of Ready to Rescue public awareness campaign to expand awareness, particularly among young adults and vulnerable communities 20,0...